Production and function of IL-12 in islets and beta cells

Diabetologia

Volumn 56, Issue 1, 2013, Pages 126-135

  Taylor Fishwick, D A ^a   Weaver, J R ^a   Grzesik, W ^a   Chakrabarti, S ^a   Green Mitchell, S ^a   Imai, Y ^a   Kuhn, N ^a   Nadler, J L ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Diabetes; Human; Interleukin 12; Islets; Pro inflammatory cytokines

Indexed keywords

CASPASE 3; CYTOKINE; GAMMA INTERFERON; GLUCOSE; INSULIN; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 1BETA; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL LINE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; UPREGULATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; CELL LINE; CELL MEMBRANE; CYTOKINES; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; INTERLEUKIN-12; ISLETS OF LANGERHANS; MICE; RECEPTORS, INTERLEUKIN-12; RNA, MESSENGER; SIGNAL TRANSDUCTION; SURFACE PROPERTIES; TISSUE CULTURE TECHNIQUES; TISSUE DONORS;

EID: 84871608983     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2732-9     Document Type: Article

References (50)

1. Katz JD, Benoist C, Mathis D (1995) T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188
2. Tisch R, McDevitt H (1996) Insulin-dependent diabetes mellitus. Cell 85:291-297 (Pubitemid 26160699)
3. Serreze DV, Chapman HD, Varnum DS, Gerling I, Leiter EH, Shultz LD (1997) Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J Immunol 158:3978-3986 (Pubitemid 127488759)
4. Trembleau S, Germann T, Gately MK, Adorini L (1995) The role of IL-12 in the induction of organ specific autoimmune diseases. Immunol Today 16:383-386
5. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L (1995) Interleukin 12 administration induces T helper type I cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181:817-821
6. Athie M, Flotow H, Hilyard KL, Cantrell DA (2000) IL-12 selectively regulates STAT4 via phosphatidylinositol 3-kinase and Ras-independent signal transduction pathways. Eur J Immunol 30:1425-1434 (Pubitemid 30311973)
7. Visconti R, Gadina M, Chiariello M et al. (2000) Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity. Blood 96:1844-1852 (Pubitemid 30662111)
8. Kaplan MH, Sun YI, Hoey T, Grusby MJ (1996) Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174-177 (Pubitemid 26242885)
9. Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O'Shea JJ (2004) Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 202:139-156 (Pubitemid 39576910)
10. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ (2003) The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 14:361-368 (Pubitemid 37099449)
11. Morinobu A, Gadina M, Strober W et al. (2002) STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation. Proc Natl Acad Sci USA 99:12281-12286
12. Nguyen T, Wang R, Russell JH (2000) IL-12 enhances IL-2 function by inducing CD25 expression through a p38 mitogen-activated protein kinase pathway. Eur J Immunol 30:1445-1452 (Pubitemid 30311975)
13. Vandenbroeck K, Alloza I, Gadina M, Matthys P (2004) Inhibiting cytokines of the interleukin-12 family: recent advances and novel challenges. J Pharm Pharmacol 56:145-160 (Pubitemid 38232744)
14. Morahan G, Huang D, Ymer SI et al. (2001) Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 27:218-221 (Pubitemid 32157453)
15. Altinova AE, Engin D, Akbay E et al. (2010) Association of polymorphisms in the IL-18 and IL-12 genes with susceptibility to Type 1 diabetes in Turkish patients. J Endocrinol Invest 33:451-454
16. Morahan G, McKinnon E, Berry J et al. (2009) Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium. Genes Immun 10(Suppl 1):S64-S68
17. Morgan D, Oliveira-Emilio HR, Keane D et al. (2007) Glucose, palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line. Diabetologia 50:359-369
18. Pi J, Bai Y, Zhang Q et al. (2007) Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 56:1783-1791 (Pubitemid 47025446)
19. Modak MA, Parab PB, Ghaskadbi SS (2009) Pancreatic islets are very poor in rectifying oxidative DNA damage. Pancreas 38:23-29
20. Mandrup-Poulsen T (2003) Apoptotic signal transduction pathways in diabetes. Biochem Pharmacol 66:1433-1440 (Pubitemid 38373330)
21. Blandino-Rosano M, Perez-Arana G, Mellado-Gil JM, Segundo C, Aguilar-Diosdado M (2008) Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide-1. J Mol Endocrinol 41:35-44
22. Lund T, Fosby B, Korsgren O, Scholz H, Foss A (2008) Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo. Transpl Int 21:669-678 (Pubitemid 351852766)
23. Boden G (2011) Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 18:139-143
24. Ma K, Nunemaker CS, Wu R, Chakrabarti SK, Taylor-Fishwick DA, Nadler JL (2010) 12-Lipoxygenase products reduce insulin secretion and β cell viability in human islets. J Clin Endocrinol Metab 95:887-893
25. Yang Z, Chen M, Ellett JD et al. (2004) Autoimmune diabetes is blocked in Stat4-deficient mice. J Autoimmun 22:191-200 (Pubitemid 38369180)
26. Yang Z, Chen M, Fialkow LB, Ellett JD, Wu R, Nadler JL (2003) The novel anti-inflammtory compound, lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice. Pancreas 26:e99-e104
27. Jorns A, Gunther A, Hedrich HJ, Wedekind D, Tiedge M, Lenzen S (2005) Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes 54:2041-2052 (Pubitemid 40911267)
28. Catalan V, Gomez-Ambrosi J, Ramirez B et al. (2007) Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg 17:1464-1474
29. Igoillo-Esteve M, Marselli L, Cunha DA et al. (2010) Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 53:1395-1405
30. Steinberg GR (2007) Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle 6:888-894 (Pubitemid 46658739)
31. 2-induced mouse islet or clonal pancreatic beta cell dysfunction. Biosci Rep 30:445-453
32. Yang ZD, Chen M, Wu R, McDuffie M, Nadler JL (2002) The anti-inflammatory compound lisofylline prevents Type 1 diabetes in non-obese diabetic mice. Diabetologia 45:1307-1314
33. Lenzen S, Drinkgern J, Tiedge M (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20:463-466 (Pubitemid 26077870)
34. Lenzen S (2008) Oxidative stress: the vulnerable beta-cell. Biochem Soc Trans 36:343-347 (Pubitemid 351839328)
35. Azevedo-Martins AK, Lortz S, Lenzen S, Curi R, Eizirik DL, Tiedge M (2003) Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells. Diabetes 52:93-101 (Pubitemid 36042112)
36. Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL (2001) Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia 44:325-332 (Pubitemid 32234459)
37. Marzorati S, Antonioli B, Nano R et al. (2006) Culture medium modulates proinflammatory conditions of human pancreatic islets before transplantation. Am J Transplant 6:2791-2795 (Pubitemid 44571702)
38. Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL (1990) Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 71:152-156
39. Larsen CM, Faulenbach M, Vaag A et al. (2007) Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517-1526 (Pubitemid 46588416)
40. Mandrup-Poulsen T, Pickersgill L, Donath MY (2010) Blockade of interleukin 1 in type 1 diabetes mellitus. Nat Rev Endocrinol 6:158-166
41. Oppmann B, Lesley R, Blom B et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-725
42. Leonardi CL, Kimball AB, Papp KA et al. (2008) Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371:1665-1674 (Pubitemid 351671883)
43. Rabinovitch A, Suarez-Pinzon WL, Sorensen O (1996) Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice. J Autoimmun 9:645-651 (Pubitemid 26370975)
44. Zipris D, Greiner DL, Malkani S, Whalen B, Mordes JP, Rossini AA (1996) Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. J Immunol 156:1315-1321
45. O'Hara RM Jr, Henderson SL, Nagelin A (1996) Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice. Ann NY Acad Sci 795:241-249 (Pubitemid 27029572)
46. Rothe H, O'Hara RM Jr, Martin S, Kolb H (1997) Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2. Diabetologia 40:641-646 (Pubitemid 27288108)
47. Trembleau S, Penna G, Gregori S, Gately MK, Adorini L (1997) Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur J Immunol 27:2330-2339 (Pubitemid 27404318)
48. Holz A, Brett K, Oldstone MB (2001) Constitutive beta cell expression of IL-12 does not perturb self-tolerance but intensifies established autoimmune diabetes. J Clin Invest 108:1749-1758 (Pubitemid 34015120)
49. Mishra M, Kumar H, Bajpai S, Singh RK, Tripathi K (2011) Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed T2DM. Diabetes Res Clin Pract 94:255-261
50. Boyton RJ, Davies S, Marden C et al. (2005) Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread. Int Immunol 17:1157-1165 (Pubitemid 41236073)